{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:49:56Z","timestamp":1781880596141,"version":"3.54.5"},"reference-count":47,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["beva.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Equine Veterinary Journal"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    <jats:bold>Reasons for performing study:<\/jats:bold>\n                    Infection with bovine papillomaviruses\n                    <jats:italic>types 1<\/jats:italic>\n                    and\n                    <jats:italic>2<\/jats:italic>\n                    (BPV\u20101, BPV\u20102) can lead to the development of therapy\u2010resistant skin tumours termed sarcoids and possibly other skin diseases in equids. Although sarcoids seriously compromise the welfare of affected animals and cause considerable economic losses, no prophylactic vaccine is available to prevent this common disease. In several animal species and man, immunisation with papillomavirus\u2010like particles (VLP) has been shown to protect efficiently from papillomaviral infection.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Hypothesis:<\/jats:bold>\n                    BPV\u20101 L1 VLPs may constitute a safe and highly immunogenic vaccine candidate for protection of horses against BPV\u20101\/\u20102\u2010induced disease.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    Three groups of 4 horses each received 50, 100 or 150\u2003\u00b5g of BPV\u20101 L1 VLPs, respectively, on Days 0, 28 and 168. Three control horses received adjuvant only. Horses were monitored on a daily basis for one week after each immunisation and then in 2 week intervals. Sera were collected immediately before, 2 weeks after each vaccination and one and 2 years after the final boost and analysed by pseudovirion neutralisation assay.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    None of the horses showed adverse reactions upon vaccination apart from mild and transient swelling in 2 individuals. Irrespective of the VLP dose, all VLP\u2010immunised horses had developed a BPV\u20101\u2010neutralising antibody titre of \u22651600 plaque forming units (pfu)\/ml 2 weeks after the third vaccination. Eight of 10 trial horses still available for follow\u2010up had neutralising antibody titres \u22651600\u2003pfu\/ml one year and \u2265800\u2003pfu\/ml 2 years after the last immunisation.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    Intramuscular BPV\u20101 L1 VLP vaccination in horses is safe and results in a long\u2010lasting antibody response against BPV\u20101. Neutralisation titres were induced at levels that correlate with protection in experimental animals and man.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Potential relevance:<\/jats:bold>\n                    BPV\u20101 L1 VLPs constitute a promising vaccine candidate for prevention of BPV\u20101\/\u20102\u2010induced disease in equids.\n                  <\/jats:p>","DOI":"10.1111\/j.2042-3306.2011.00390.x","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T22:09:36Z","timestamp":1315346976000},"page":"107-111","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Safety and immunogenicity of BPV\u20101 L1 virus\u2010like particles in a dose\u2010escalation vaccination trial in horses"],"prefix":"10.1111","volume":"44","author":[{"given":"E. K.","family":"HAINISCH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"BRANDT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"SHAFTI\u2010KERAMAT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"VAN DEN HOVEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"KIRNBAUER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1128\/jvi.35.3.962-964.1980","article-title":"Equine connective tissue tumours contain unintegrated bovine papilloma virus DNA","volume":"35","author":"Amtmann E.","year":"1980","journal-title":"J. Virol."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.83267-0"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2008022"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.02.014"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2010.12.021"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-3306.2010.00147.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.69.6.3959-3963.1995"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.2.751-757.2004"},{"key":"e_1_2_7_10_1","unstructured":"Buck C.B. Pastrana D.V. Lowy D.R.andSchiller J.T.(2008)Production of papillomaviral vectors (pseudoviruses).http:\/\/home.ccr.cancer.gov\/lco\/pseudovirusproduction.htm. Last update 2008 01.02.2009. Accessed 2009 12\/02."},{"key":"e_1_2_7_11_1","first-page":"1","volume-title":"Papillomavirus Research: From Natural History to Vaccines and Beyond","author":"Campo M.S.","year":"2006"},{"key":"e_1_2_7_12_1","first-page":"373","volume-title":"Papillomavirus Research: From Natural History to Vaccines and beyond","author":"Campo M.S.","year":"2006"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2001.62.741"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.18947-0"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0739(02)00027-5"},{"key":"e_1_2_7_16_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/jvi.67.1.315-322.1993","article-title":"Self\u2010assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins","volume":"67","author":"Hagensee M.E.","year":"1993","journal-title":"J. Virol."},{"key":"e_1_2_7_17_1","unstructured":"Hainisch E.K. Hartl B. Kainzbauer C. Tober R. Shafti\u2010Keramat S. Kirnbauer R.andBrandt S.(2010)Intact BPV\u20101 virion is required for experimental tumour induction in foals and causes viraemia. In:Proceedings of the 26th International Papillomavirus Conference July 3\u20108 2010 Montreal Canada.http:\/\/www.hpvmedia.org\/index.php?option=com_hpv&view=presentations&limitstart=0&Itemid=199."},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.09.073"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1159\/000150475"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.24.12180"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0220"},{"key":"e_1_2_7_22_1","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1128\/jvi.67.12.6929-6936.1993","article-title":"Efficient self\u2010assembly of human papillomavirus type 16 L1 and L1\u2010L2 into virus\u2010like particles","volume":"67","author":"Kirnbauer R.","year":"1993","journal-title":"J. Virol."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(81)90433-5"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0818-9641.2004.01286.x"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.014746-0"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.83266-0"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2008.00683.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(02)00123-5"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.049"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01309847"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60946-5"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2003.12.027"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2005.04.011"},{"key":"e_1_2_7_34_1","first-page":"2221","article-title":"Intracranial fibroblastic neoplasms in the hamster from bovine papilloma virus","volume":"32","author":"Robl M.G.","year":"1972","journal-title":"Cancer Res."},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.70.5.3298-3301.1996"},{"key":"e_1_2_7_36_1","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1128\/jvi.67.4.1936-1944.1993","article-title":"Expression of human papillomavirus type 11 L1 protein in insect cells: In vivo and in vitro assembly of virus\u2010like particles","volume":"67","author":"Rose R.C.","year":"1993","journal-title":"J. Virol."},{"key":"e_1_2_7_37_1","doi-asserted-by":"crossref","unstructured":"Schiller J.T.(1997)pSHELL.http:\/\/home.ccr.cancer.gov\/lco\/pSheLL.htm. Last update 1997 30.6.1997. Accessed 2009 12\/02.","DOI":"10.1016\/S0960-2593(97)88489-3"},{"key":"e_1_2_7_38_1","unstructured":"Schiller J.T.(1998)pYSEAP.http:\/\/home.ccr.cancer.gov\/lco\/pYSEAP.htm. Last update 1998 10.3.1998. Accessed 2009 12\/02."},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-36523-7_14"},{"key":"e_1_2_7_40_1","first-page":"719","volume-title":"Equine Dermatology","author":"Scott D.W.","year":"2003"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.07.036"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1024\/0036-7281.149.4.161"},{"key":"e_1_2_7_43_1","first-page":"21","article-title":"Equine sarcoid","volume":"8","author":"Sullins K.E.","year":"1986","journal-title":"Equine Pract."},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11553"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(05)70101-7"},{"key":"e_1_2_7_46_1","first-page":"183","article-title":"Transmission of equine sarcoid","volume":"30","author":"Voss J.L.","year":"1969","journal-title":"Am. J. vet. Res."},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2006.10.012"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.21.120601.141045"}],"container-title":["Equine Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.2042-3306.2011.00390.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.2042-3306.2011.00390.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T07:52:41Z","timestamp":1762069961000},"score":1,"resource":{"primary":{"URL":"https:\/\/beva.onlinelibrary.wiley.com\/doi\/10.1111\/j.2042-3306.2011.00390.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,6]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.2042-3306.2011.00390.x"],"URL":"https:\/\/doi.org\/10.1111\/j.2042-3306.2011.00390.x","archive":["Portico"],"relation":{},"ISSN":["0425-1644","2042-3306"],"issn-type":[{"value":"0425-1644","type":"print"},{"value":"2042-3306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,6]]},"assertion":[{"value":"2011-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}